Bayer says expects Xarelto peak sales at end of decade

FRANKFURT Thu Feb 28, 2013 6:16am EST

Related Topics

FRANKFURT Feb 28 (Reuters) - Bayer expects the drugmaker's promising new stroke prevention drug Xarelto to reach its peak annual sales at the end the decade, Chief Executive Marijn Dekkers said on Thursday.

Bayer has said that Xarelto has a peak sales potential of more than 2 billion euros ($2.62 billion). ($1 = 0.7628 euros) (Reporting by Ludwig Burger)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.